News FDA Authorizes Emergency Use of Actemra for COVID-19 Publish Date June 28, 2021 The EUA was issued based on 4 randomized controlled clinical trials that evaluated the efficacy and safety of Actemra in more than 5500 hospitalized patients with COVID-19.
Drugs in the Pipeline Mixed Results for Baricitinib in Trial of Hospitalized COVID-19 Patients Publish Date April 8, 2021 Findings showed that the trial did not meet statistical significance on the primary endpoint.